tirzepatide kaiser cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says Has anyone successfully obtained tirzepatide

So I guess my question for Rahul or for Josh is does that impact the way that you sort of think about these results

Though they did not achieve their primary endpoints, response rates trended higher in rituximab than the placebo groups, she said

10.1021/acs.molpharmaceut.9b00132 Mol

GLOW is a research peptide blend developed for laboratory investigations into skin biology, collagen pathways, cellular repair, and tissue regeneration

Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, Katz J, Feinberg MW, Gerzsten RE, Edelman ER, Jain MK

We also want to determine whether other GLP-1 drugs can deliver the same relief, possibly with even fewer gastrointestinal side effects, Dr Braca noted